Companies:
53,025
Total Market Cap:
168990884340874.08
Global Rank
#134
Country Rank
#78
Market Cap
151.52 B
Price
86.99
Change (%)
0.02%
Volume
10.44 M
Abbott Laboratories's latest marketcap:
151.52 B
As of 06/04/2026, Abbott Laboratories's market capitalization has reached $151.52 B. According to our data, Abbott Laboratories is the 134th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 151.52 B |
| Revenue (ttm) | 45.13 B |
| Net Income (ttm) | 6.25 B |
| Shares Out | 1.74 B |
| EPS (ttm) | 3.57 |
| Forward PE | 15.53 |
| Ex-Dividend Date | 04/15/2026 |
| Earnings Date | 07/16/2026 |
Market Cap Chart
Data Updated: 06/04/2026
Abbott Laboratories's yearly market capitalization.
Abbott Laboratories has seen its market value grow from $74.36 B to $151.52 B since 1998, representing a total increase of 103.76% and an annual compound growth rate (CAGR) of 2.63%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/04/2026 | $151.52 B | -30.45% | 134 |
| 12/31/2025 | $217.86 B | 11.05% | 55 |
| 12/31/2024 | $196.18 B | 2.67% | 64 |
| 12/29/2023 | $191.09 B | -0.18% | 59 |
| 12/30/2022 | $191.43 B | -23.08% | 50 |
| 12/31/2021 | $248.87 B | 28.25% | 45 |
| 12/31/2020 | $194.06 B | 26.33% | 49 |
| 12/31/2019 | $153.61 B | 20.92% | 52 |
| 12/31/2018 | $127.04 B | 27.88% | 53 |
| 12/29/2017 | $99.34 B | 75.66% | 92 |
Company Profile
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Founded in 1888 and headquartered in North Chicago, Illinois, the company operates across four key business segments.
Business Segments
- Established Pharmaceutical Products – Offers generic pharmaceuticals for conditions such as pancreatic exocrine insufficiency, hypertension, hypothyroidism, pain, inflammation, and more.
- Diagnostic Products – Provides laboratory and transfusion medicine systems, molecular diagnostics, point-of-care testing, and rapid diagnostics.
- Nutritional Products – Supplies pediatric and adult nutritional products, including infant formula.
- Medical Devices – Includes cardiovascular devices, diabetes care products, and neuromodulation devices for chronic pain and movement disorders.
Key Offerings
- Generic pharmaceuticals for a wide range of medical conditions.
- Advanced diagnostic systems for immunoassay, clinical chemistry, and molecular testing.
- Nutritional solutions for infants and adults.
- Innovative medical devices for cardiovascular, diabetes, and neurological care.
Frequently Asked Questions
-
What is Abbott Laboratories's (ABT) current market cap?As of 06/04/2026, Abbott Laboratories (including the parent company, if applicable) has an estimated market capitalization of $151.52 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Abbott Laboratories (ABT) rank globally by market cap?Abbott Laboratories global market capitalization ranking is approximately 134 as of 06/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.